Tag: trial

Alzheimer’s drug trial targets by-product of gum disease

The pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer’s drug that targets toxic substances released by P. gingivalis, a bacteria linked to gum disease. In a poster presented at the Alzheimer’s Association International Conference today (Wednesday, July 17), researchers provided an overview of the development of the drug, known as COR388, and

Early trial shows promise for MDMA as an alcoholism treatment

Scientists use ECSTASY to ‘cure alcoholics’: Four people give up heavy drinking after taking two doses of MDMA alongside psychotherapy in eight-week trial, study claims Scientists from Imperial College London teamed up with mental health workers They trialled a combination of counselling with taking the recreational drug None of the four people were drinking harmfully

Trial remedies racial disparities in treatment for early-stage lung and breast cancer patients

Results from a study published in the Journal of the National Medical Association show that a pragmatic system-based intervention within cancer treatment centers can nearly eliminate existing disparities in treatment and outcomes for black patients with early-stage lung and breast cancer. The treatment completion rates before this intervention were 87.3 percent for white patients versus

Small Trial Provides New Hope Against Parkinson’s Disease

FRIDAY, March 1, 2019 — It may be possible to restore brain cells damaged by Parkinson’s disease and reverse a patient’s condition, something no current treatment can do, according to British researchers who conducted potentially groundbreaking clinical trials. They cautioned the trial was small — just 41 patients — and the research is still in

Early-stage clinical trial of antimalarial drug begins

Enrollment has begun in a Phase 1 clinical trial to test the safety of a new investigational drug designed to treat malaria, as well as its effect on the human body. The first-in-human study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and

Research trial aims to reduce major cause of birth disabilities

Researchers are beginning recruitment in a trial to see if changing pregnant women’s hygiene habits could reduce the risks of a major cause of childhood disabilities. Cytomegalovirus, or CMV, is the most common congenital infection in the UK, affecting around 1000 babies every year. If babies are infected while in the womb it can result

NIH begins clinical trial of live, attenuated Zika vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg